Universitätsklinikum Münster

Changes of disease characteristics and disease-modifying treatment within one year in the National German MS cohort (2018) Ambrosius B, Hessler N, Antony G, Konig IR, Hoshi MM, Aly L, Luessi F, et al. Conference contribution Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations (2018) Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, et al. Journal article DNA methylation-based classification of central nervous system tumours (2018) Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, et al. Journal article Metastatic castration-resistant prostate cancer. Use of cabazitaxel taking into consideration current data (2018) Gschwend JE, Albers P, Boegemann M, Goebell P, Heidenreich A, Klier J, Koenig F, et al. Journal article Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study (2018) Huhn K, Bayas A, Doerck S, Frank B, Gerbershagen K, Hellwig K, Kallmann B, et al. Journal article Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial (2018) Kuhlen M, Bader P, Sauer M, Albert MH, Gruhn B, Gungor T, Kropshofer G, et al. Journal article Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy (2018) Hoffmann A, Ettle B, Battis K, Reiprich S, Schlachetzki J, Masliah E, Wegner M, et al. Journal article Publisher Correction: Nfat/calcineurin signaling promotes oligodendrocyte differentiation and myelination by transcription factor network tuning (2018) Weider M, Starost LJ, Groll K, Küspert M, Sock E, Wedel M, Fröb F, et al. Journal article, Erratum Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL (2018) Boegemann M, Bedke J, Schostak M, Welslau M, Hering-Schubert C, Wolf T, Schleicher J, et al. Conference contribution Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article